The Nose Knows: Study Establishes Airborne Exposure to Microcystins
A study explored the link between human nasal and environmental microcystin concentrations from harmful algal blooms and detected the toxin in the nasal passages of 95 percent of the participants.
Board of Trustees Meeting Ushers in New Chair, New Vice Chair Elected
The 性视界传媒 Board of Trustees met today for its committee and full board meetings to discuss university business, as well as elect Shaun Davis as its new vice chair.
性视界传媒Presents 'Only One' Play About Sex Trafficking
FAU's School of Criminology and Criminal Justice, along with the Peace, Justice and Human Rights Initiative, present "Only One".
Oh My Aching Back: Do Yoga, Tai Chi or Qigong Help?
Researchers provide a comprehensive review of the effects of movement-based mind-body interventions on chronic low back pain.
Choosing Common Pain Relievers: It's Complicated
性视界传媒Schmidt College of Medicine researchers examine benefits and risks of nonsteroidal anti-inflammatory drugs to provide guidance to health care providers and their patients in their clinical decision-making.
Researchers Take Body Armor to the Next Level with High Energy Fibers
FAU's College of Engineering and Computer Science received $569,482 from Combating Terrorism Technical Support Office to develop advanced fibers to enhance the performance of military helmets and body armor.
性视界传媒to Host Events in Honor of Black/African American History Month
性视界传媒 will celebrate Black/African American History Month with a series of events throughout the month of February at its Boca Raton, Jupiter and Broward campuses.
性视界传媒Receives Carnegie Foundation Community Engagement Classification
The Carnegie Foundation has announced that 性视界传媒 is one of the 119 U.S. colleges and universities to receive the Carnegie Community Engagement Classification for 2020.
Study Shows New Way to Treat Stroke Using an Already FDA-Approved Drug
Researchers from FAU's Schmidt College of Medicine are the first to report on the neuroprotective properties of granulocyte colony-stimulating factor, an already FDA-approved drug.
Genetic Testing in Diverse Young Breast Cancer Patients over a Decade
Researchers examined racial and ethnic differences in genetic testing frequency and results among diverse breast cancer patients diagnosed at age 50 or younger from January 2007 to December 2017.